FSSNX
Price
$28.13
Change
+$0.28 (+1.01%)
Updated
Jul 3 closing price
Net Assets
25.56B
VCSLX
Price
$15.85
Change
+$0.15 (+0.96%)
Updated
Jul 3 closing price
Net Assets
1.08B
Interact to see
Advertisement

FSSNX vs VCSLX

Header iconFSSNX vs VCSLX Comparison
Open Charts FSSNX vs VCSLXBanner chart's image
Fidelity Small Cap Index
Price$28.13
Change+$0.28 (+1.01%)
VolumeN/A
Net Assets25.56B
VALIC Company I Small Cap Index
Price$15.85
Change+$0.15 (+0.96%)
VolumeN/A
Net Assets1.08B
FSSNX vs VCSLX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSSNX vs. VCSLX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSSNX is a StrongBuy and VCSLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 25.6B vs. VCSLX (1.08B). VCSLX pays higher dividends than FSSNX: VCSLX (1.26) vs FSSNX (0.92). FSSNX was incepted earlier than VCSLX: FSSNX (14 years) vs VCSLX (33 years). VCSLX (0.43) is less costly to investors than FSSNX (0.03). VCSLX is a more actively managed with annual turnover of: 11.00 vs. FSSNX (9.00). FSSNX (0) and VCSLX (0) have matching initial minimum investment requirements. FSSNX annual gain was more profitable for investors over the last year : 12.15 vs. VCSLX (7.62). FSSNX return over 5 years is better than : 64.11 vs. VCSLX (7.91).
FSSNXVCSLXFSSNX / VCSLX
Total Expense Ratio0.030.377%
Annual Report Gross Expense Ratio0.030.436%
Fund Existence14 years33 years-
Gain YTD1.626-2.271-72%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets25.6B1.08B2,379%
Annual Yield % from dividends0.921.2673%
Returns for 1 year12.157.62159%
Returns for 3 years36.672.071,767%
Returns for 5 years64.117.91811%
Returns for 10 years77.87-15.98-487%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RGBPP0.06N/A
+8.80%
Regen Biopharma, Inc.
KRMCF0.44N/A
N/A
KRM22 PLC
IRRHF2389.97N/A
N/A
Interroll Holdings SA
KNBWY14.07-0.07
-0.50%
Kirin Holdings Co., Ltd.
NLCP13.91-0.19
-1.35%
NewLake Capital Partners, Inc.